In the Weill Cornell News...
Missing Link Identified Between Immune Cells and Alzheimer’s. By studying the effects of immune cells that surround blood vessels in the brain, Weill Cornell Medicine researchers have discovered a new pathway involving these cells that may contribute to the cause of Alzheimer’s disease.
https://news.weill.cornell.edu/news/2017/07/missing-link-identified-between-immune-cells-and-alzheimer’s- NIH Precision Medicine Grant awarded to four NYC institutions. Dr. M. Elizabeth Ross of BMRI participates in the Precision Medicine Initiative Cohort Program. http://news.weill.cornell.edu/news/2016/07/nih-awards-five-year-grant-to-four-new-york-city-medical-centers-to-advance-precision-medicine
- BMRI scientists Drs. Josef Anrather, Corinne Benakis and David Brea discover a link between gut bacteria and stroke outcome.
- Dr. Costantino Iadecola provides insights to vascular drivers of Alzheimer’s disease.
- Dr. Giovanni Manfredi is featured in an article on the link between mitochondrial dysfunction and diseases like ALS.
- Dr. Costantino Iadecola provides commentary on a new study, published in Nature, which found evidence that Alzheimer’s disease may be transmissible via extracts contaminated with amyloid-β.
- Dr. Gregory A. Petsko discusses the possibility of lowering one's risk of Alzheimer's disease.
- Dr. Christopher Mason receives superb recognition for his recent project in which he mapped the NYC Subway Microbiome. For additional details, please see the following articles:
- http://www.the-scientist.com/?articles.view/articleNo/42117/title/Subway...
- http://www.cnn.com/2015/02/07/us/new-york-subway-germs/index.html
- http://www.npr.org/blogs/health/2015/02/06/384274314/what-microbes-lurk-...
- ttp://hereandnow.wbur.org/2015/02/06/microbes-nyc-subway
- http://www.pbs.org/newshour/bb/christopher-mason-interivew/
- http://nymag.com/daily/intelligencer/2015/02/how-disgusting-is-your-subw...
- Dr. Christopher Mason has been selected as one of Popular Science’s “Brilliant 10,” for his groundbreaking work in sequencing genes and his development of a technique to map out the chemical tags not only in DNA but RNA.
- Dr. Hooman Kamel was featured in the New York Times for his recent research on heart surgery and its association with future risk of stroke.
- Dr. Steven Paul, BMRI Faculty member and Former Lilly R&D Chief, Takes Head Seat at Voyager
- Dr. Makoto Ishii helped discover that accumulation of a peptide called amyloid-beta inside the brain disrupts the body's mechanism to regulate its weight, leading to accelerated weight loss years before Alzheimer's diagnosis.
- Dr. Nicholas Schiff and colleagues find common loss of function across brain circuit in severe brain injury -- as well as possible ways to switch it back on.
- Dr. M. Flint Beal reveals that use of Coenzyme Q10 (CoQ10) showed no evidence of clinical benefit in 600 patients with Parkinson's disease, a disappointing finding.
- Dr. Christopher Mason, suited with a 3 year grant from NASA, strives to understand how the human body responds to space travel at the molecular level. He does so by studying the only pair of genetically identical twins who've actually left Earth's atmosphere.
- Dr. M. Elizabeth Ross and colleagues reveal a new genetic route to megalencephaly, or MEG — a growth and development disorder in which the brain is abnormally large.
- Dr. Hooman Kamel leads a study that finds the risk of serious blood clots extends to 12 weeks after childbirth. Researchers find risk lasts twice as long as previously thought.
- Dr. Gregory Petsko and a team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University have devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.
- Dr. M. Elizabeth Ross and her team of neuroscientists has reversed psychosis-like features in mice, raising hope that scientists may ultimately be able to do the same for humans with schizophrenia.
- Dr. Nicholas Schiff and his team of researchers discover idling brain activity in severely brain injured patients who "Wake Up" after using a sleep drug.
- Dr. Costantino Iadecola is featured in Weill Cornell's "Research Highlight: Stopping Vascular Dementia".
- Dr. Timothy Vartanian and his research team have identified a bacterium they believe may trigger multiple sclerosis (MS).
- Dr. Costantino Iadecola and his team of researchers at Weill Cornell Medical College have discovered that amyloid peptides are harmful to the blood vessels that supply the brain with blood in Alzheimer's disease
Awards, Articles, & Videos
- Dr. Costantino Iadecola was the keynote speaker at the 11th International Symposium on Resistance Arteries (ISRA), Banf, Alberta, Canada.
- Dr. Costantino Iadecola gave the keynote address at the American Heart Association, Fall Conference for Council on High Blood Pressure Research, San Francisco, CA.
- Dr. Jonathan Victor was the keynote speaker for Neurostats 2014 in Coventry UK.
- Dr. Christopher Mason is asked by NASA to compare the DNA and RNA of twin astronauts after spending a year in space. He is mentioned in "Popular Science" magazine here:
- Dr. Jennifer Linden, BMRI Post-doctoral fellow in Dr. Timothy Vartanian's lab, received a "Young Investigator Award for Oral Presentations" at the MS Boston 2014 conference. Her talk was entitled "In-Vivo administration of C. perfringens epsilon toxic target cells and their association with Multiple Sclerosis "
- Dr. Barbara Hempstead is appointed Senior Associate Dean for Education at WCMC and plans to lead efforts in providing students with the very best education and training.
- Dr. M. Elizabeth Ross was awarded the Weill Cornell Graduate School of Medical Sciences Distinguished Alumna Award in honor of her distinguished contributions to biomedical research and education.
- Dr. Timothy Hla (North American Coordinator) and Dr. Costantino Iadecola (Project leader) have been awarded a Transatlantic Networks of Excellence Program from the Leducq Foundation.
- Dr. Costantino Iadecola presents at the 2014 Zilkha Symposium on Alzheimer's disease. This article touches on his pivotal work being done that was presented at the meeting.
- Dr. Gregory Petsko is appointed Director of the Appel Alzheimer's Disease Research Institute.
- A webinar with Dr. Costantino Iadecola on the neurovascular underpinnings of cognitive decline.
- An interesting YouTube clip on Translational Research being done by Drs. Christopher Mason and M. Elizabeth Ross.
- Weill Cornell's new Belfer Research Building is the architectural reflection of the medical college's vision for 21st century translational research. It's also an archetype for a green, high-rise laboratory facility — a rare structure in an urban setting like Manhattan.
- Dean Glimcher interviews Drs. Costantino Iadecola and Matthew Fink.
- Dr. Norman Relkin presents his Phase 3 Trial of IVIG data at International Alzheimer's Disease Conference.
- Alzheimer's disease is one of today's most devastating afflictions, but according to Weill Cornell Medical College researchers, there is reason to have hope.
- New Feil Family Brain and Mind Research Institute Established at Weill Cornell Medical College